read more

first_imgFeature | February 11, 2015 Many Mastectomy Patients with Locally Advanced Breast Cancer Not Getting Post-Op Radiation Study finds women more likely to get radiation therapy after receiving chemotherapy Image courtesy of Imago Systems News | PACS | August 09, 2019 Lake Medical Imaging Selects Infinitt for Multi-site RIS/PACS Infinitt North America will be implementing Infinitt RIS (radiology information system)/PACS (picture archiving and… read more News | Mammography | August 14, 2019 Imago Systems Announces Collaboration With Mayo Clinic for Breast Imaging Image visualization company Imago Systems announced it has signed a know-how license with Mayo Clinic. The multi-year… read more News | Proton Therapy | August 06, 2019 IBA Signs Contract to Install Proton Therapy Center in Kansas IBA (Ion Beam Applications S.A.) recently signed a contract and received the first payment for a Proteus One solution… read more News | Patient Positioning Radiation Therapy | August 07, 2019 Qfix kVue One Proton Couch Top Validated by Mevion Medical Systems Qfix and Mevion Medical Systems announced that a special version of the kVue One Proton couch top is now both validated… read more February 11, 2015 — Breast cancer patients who undergo a mastectomy should receive subsequent radiation treatment if their cancer has spread to four or more nearby lymph nodes. However, according to a new study, only 65 percent of these women are getting the recommended postmastectomy radiation therapy (PMRT). The researchers looked at nearly 57,000 cases of breast cancer, and their study has been published as an “article in press” on the Journal of the American College of Surgeons website.Several studies have found that PMRT reduces the risk of breast cancer recurrence and improves survival in patients whose cancer is “locally advanced” with a pathologic stage of N2 or N3 using the American Joint Committee on Cancer (AJCC) staging system. The AJCC defines N2 cancer primarily as having spread to between four and nine axillary, or underarm, lymph nodes but no other organs; N3 disease involves 10 or more axillary lymph nodes.”My colleagues and I were quite startled by the finding that a third of patients with N2/N3 disease did not receive PMRT, which is the standard of care,” said lead author Quyen D. Chu, M.D., MBA, FACS, professor of surgery at Louisiana State University Health Sciences Center, Shreveport.Since 2000, the National Cancer Institute and the American Society of Clinical Oncology have recommended PMRT, in addition to chemotherapy, for most breast cancer patients who opt for breast removal and have a high risk of tumor recurrence in the chest area. This risk group includes women with four or more positive (cancerous) lymph nodes. For this study, the investigators evaluated compliance with the treatment guidelines using the National Cancer Data Base (NCDB), a joint project of the American College of Surgeons Commission on Cancer (CoC) and the American Cancer Society.From 2.72 million breast cancer cases diagnosed between 1998 and 2011 and listed in the database, 56,990 files of women with N2 or N3 cancer were found. The researchers evaluated these de-identified files to determine factors linked to receipt of PMRT. According to statistical analyses, only three factors independently predicted a higher likelihood that patients would receive PMRT: receipt of chemotherapy, readmission to the hospital within the first month after breast removal and being alive 30 days after the operation.Women with N2 or N3 breast cancer were 5.4 times more likely to get radiation therapy after mastectomy if they also received chemotherapy. In all, 82.1 percent of patients received chemotherapy. Chu theorized that women who chose not to receive chemotherapy might also have been unwilling to accept radiation therapy.Breast cancer patients had 1.14 times the odds of receiving PMRT if they were readmitted to the hospital within 30 days postoperatively because of complications or other reasons. Chu suggested that hospital care providers may realize that the patient was not referred for radiation therapy, making an early readmission “a point to remedy the error” of noncompliance with treatment guidelines.”From this study, we could not tease out whether patients refuse treatment or there is a lack of awareness among women and physicians about the need for radiation therapy after mastectomy for locally advanced breast cancer,” Chu said. “If women with N2/N3 breast cancer who plan a mastectomy are not offered PMRT, they should ask their physician why.”Exceptions to the PMRT recommendation for high-risk breast cancers include women who had prior radiation therapy or have connective tissue disorders.For more information: www.facs.org FacebookTwitterLinkedInPrint分享 Related Content News | Patient Positioning Radiation Therapy | August 15, 2019 Mevion and C-RAD Release Integration for Improved Proton Therapy Treatment Quality Mevion Medical Systems and C-RAD announced the integration between the C-RAD Catalyst PT and the Mevion S250i proton… read more News | Artificial Intelligence | August 13, 2019 Artificial Intelligence Could Yield More Accurate Breast Cancer Diagnoses University of California Los Angeles (UCLA) researchers have developed an artificial intelligence (AI) system that… read more Following radiation, the bone marrow shows nearly complete loss of blood cells in mice (left). Mice treated with the PTP-sigma inhibitor displayed rapid recovery of blood cells (purple, right). Credit: UCLA Broad Stem Cell Research Center/Nature Communications News | Proton Therapy | August 08, 2019 MD Anderson to Expand Proton Therapy Center The University of Texas MD Anderson Cancer Center unveiled plans to expand its Proton Therapy Center during a… read more News | Brachytherapy Systems | August 14, 2019 Efficacy of Isoray’s Cesium Blu Showcased in Recent Studies August 14, 2019 — Isoray announced a trio of studies recently reported at scientific meetings and published in medica read more Catalyst PT image courtesy of C-RAD The MD Anderson Proton Therapy Center expansion is expected to be completed in 2023. Rendering courtesy of Stantec. News | Radiation Therapy | August 15, 2019 First Patient Enrolled in World’s Largest Brain Cancer Clinical Trial Henry Ford Cancer Institute is first-in-the-world to enroll a glioblastoma patient in the GBM AGILE Trial (Adaptive… read more News | Radiation Therapy | August 16, 2019 Drug Accelerates Blood System’s Recovery After Radiation, Chemotherapy A drug developed by UCLA physician-scientists and chemists speeds up the regeneration of mouse and human blood stem… read more last_img read more

Cyprus records the largest unemployment annual fall in the EU

first_imgCyprus registered, once again, the largest annual decrease in unemployment for August 2018, according to Eurostat, the statistical office of the European Union.Unemployment in Cyprus dropped from 10.5% in August 2017 to 7.5% (7.0% in males and 7.9% in females) for August 2018 (or from 45 000 to 33 000 individuals), further down form 7.6% in July 2018.Meanwhile, the euro area (EA19) seasonally-adjusted unemployment rate was 8.1% in August 2018, down from 8.2% in July 2018 and from 9.0% in August 2017. This is the lowest rate recorded in the euro area since November 2008.The EU28 unemployment rate was 6.8% in August 2018, stable compared with July 2018 and down from 7.5% in August 2017.This remains the lowest rate recorded in the EU28 since April 2008.Eurostat estimates that 16.657 million men and women in the EU28, of whom 13.220 million in the euro area, were unemployed in August 2018. Compared with July 2018, the number of persons unemployed decreased by 114 000 in the EU28 and by 102 000 in the euro area. Compared with August 2017, unemployment fell by 1.921 million in the EU28 and by 1.419 million in the euro area.Among the member states, the lowest unemployment rates in August 2018 were recorded in the Czech Republic (2.5%), Germany and Poland (both 3.4%). The highest unemployment rates were observed in Greece (19.1% in June 2018) and Spain (15.2%). Compared with a year ago, the unemployment rate fell in all Member States.The largest decreases were registered in Cyprus (from 10.5% to 7.5%), Croatia (from 10.9% to 8.5%), Greece (from 21.3% to 19.1% between June 2017 and June 2018) and Portugal (from 8.8% to 6.8%). In August 2018, the unemployment rate in the United States was 3.9%, stable compared with July 2018 and down from 4.4% in August 2017.In August 2018, 3.315 million young persons (under 25) were unemployed in the EU28, of whom 2.367 million were in the euro area. Compared with August 2017, youth unemployment decreased by 431 000 in the EU28 and by 275 000 in the euro area. In August 2018, the youth unemployment rate was 14.8% in the EU28 and 16.6% in the euro area, compared with 16.6% and 18.5% respectively in August 2017. In August 2018, the lowest rates were observed in Germany (6.2%), the Czech Republic (6.3%) and the Netherlands (7.7%), while the highest were recorded in Greece (39.1% in June 2018), Spain (33.6%) and Italy (31.0%).CNAYou May LikeUltimate Pet Nutrition Nutra Thrive SupplementAdd This One Thing To Your Dog’s Food To Help Them Be HealthierUltimate Pet Nutrition Nutra Thrive SupplementUndoDr. Marty ProPower Plus Supplement3 Dangerous Foods People Feed Their Dogs (Without Realizing It)Dr. Marty ProPower Plus SupplementUndoPopularEverythingColorado Mom Adopted Two Children, Months Later She Learned Who They Really ArePopularEverythingUndo Turkish Cypriot actions in Varosha ‘a clear violation’ of UN resolutions, Nicosia saysUndoConcern over falling tourism numbersUndoAuthorities release five of 12 Israeli rape suspects, seven due in court FridayUndoby Taboolaby Taboolalast_img read more